The investigation is based on unpublished research from a study of a small number of pancreatic tissue specimens taken from patients after death from unspecified causes.

Currently, no new conclusions about the safety of these drugs have been reached. The FDA has requested methodology used to collect and study these specimens, and the tissue samples used, so it can further investigate.

The FDA said that health care professionals should continue to follow the prescribing recommendations in the drug labels, but they are also encouraged to report adverse events or side effects to the FDA.

To report issues:• Complete and submit the report online: www.fda.gov/MedWatch/report.htm• Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

Already Registered? Login Now:

Register Today - It's Free!

Do you have a good teaching case with an accompanying clinical photograph (or 2)? We are inviting fresh new cases on any aspect of primary care. We offer a $75 honorarium for accepted cases. More details on submission, here.